Many now asking for generic medicines amid cost-of-living concerns, survey finds

Almost half of respondents to a recent survey said that cost is 'very important' when buying generic medicines, but this was less so for younger people.

Four in 10 consumers now buy generic, cheaper versions of everyday medicine, with almost as many delaying treatment as the cost of living bites, an analysis of medicines spending has found.

Over-the-counter medicines for common illnesses or pain relief are often available in pharmacies as popular brand-name products or generic medicines. The latter are usually cheaper than the big-name products.

The Azure Pharmaceuticals survey has found 40% of 1,000 people surveyed earlier this year said they now look for cheaper alternatives instead of brand-name medicines.

Another 26% said they now buy over-the-counter medicines less often. The research commissioned by Azure found 36% said the cost of these medicines “stopped them buying something they needed”.

Some 79% of people said they want to know more about better-value options.

What's your view on this issue?

You can tell us here

Azure Pharmaceuticals managing director Sandra Gannon said: “What we are seeing is a shift in how people engage with everyday healthcare.” 

She said in pharmacies that “patients are asking more questions about price, looking for alternatives, and in some cases, delaying treatment altogether".

“That has implications not just for individuals, but for the wider health system," she said.

She said that it is not yet clear whether this is a snap reaction to the current conditions or something which could continue.

Some 47% said cost is “very important” when buying these medicines, but this was less so for younger people.

The research stated that “22% of those aged 18 to 24 years said price was unimportant, twice the level and more of other age cohorts”.

Ms Gannon suggested this age group is “more likely to prioritise convenience and explore alternative purchasing channels".

The survey of 1,000 adults was carried out between February 26 and March 2 this year by Amárach Research for Azure Pharmaceuticals.

In response, the Irish Pharmacy Union said its members see customers “often request products by brand name”.

A spokesman said this could be because they already know the medicine, or it could be the influence of “significant marketing campaigns”.

He said: “As a result, people can sometimes be reluctant to switch to a generic alternative, even when it’s equally effective.” 

However, he added: “Patient preferences and trust in certain brands can still be a barrier in day-to-day practice.”